The Approach to Children with Recurrent Infections
,
Abstract
Recurrent and chronic infections in children are one of the most common reasons for physicians' visits that make a diagnostic challenge to pediatricians. Although the majority of referred children with recurrent infections are normal, underlying causes of recurrent infection such as atopy, anatomical and functional defects, and primary or secondary immunodeficiency must be considered in evaluation of children with this complaint.
Although primary immunodeficiency diseases (PIDs) were originally felt to be rare, it has became clear that they are much more common than routinely appreciated. Early and accurate detection of PIDs in children is essential to institute early lifesaving care and optimized treatments.
Therefore in the approach to children with recurrent infections, careful medical history taking and physical examination with more attention to warning PIDs signs and symptoms are essential to distinguish those children with underlying PIDs from those who are normal or having other underlying disorders. If indicated, appropriate laboratory studies including simple screening and advanced tests must be performed.
1. Ballow M. Approach to the patient with recurrent infec- tions. Clin Rev Allergy Immunol 2008; 34(2):129-40.
2. Couriel J. Assessment of the child with recurrent chest infections. Br Med Bull 2002; 61:115-32.
3. Geha RS, Notarangelo LD, Casanova JL, Chapel H, Conley ME, Fischer A, et al. Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee. J Allergy Clin Immunol 2007; 120(4):776-94.
4. Campbell H. Acute respiratory infection: a global challenge. Arch Dis Child 1995; 73(4):281-3.
5. Gruber C, Keil T, Kulig M, Roll S, Wahn U, Wahn V.History of respiratory infections in the first 12 yr among children from a birth cohort. Pediatr Allergy Immunol 2008; 19(6):505-12.
6. Monto AS. Viral respiratory infections in the community: epidemiology, agents, and interventions. Am J Med 1995; 99(6B):24S-7S.
7. Environmental tobacco smoke: a hazard to children.American Academy of Pediatrics Committee on Environmental Health. Pediatrics 1997; 99(4):639-42.
8. Spencer N, Coe C. Parent reported longstanding health problems in early childhood: a cohort study. Arch Dis Child 2003; 88(7):570-3.
9. Aligne CA, Stoddard JJ. Tobacco and children. An economic evaluation of the medical effects of parental smoking. Arch Pediatr Adolesc Med 1997; 151(7):648-53.
10. Dykewicz MS. Rhinitis and sinusitis. J Allergy Clin Immunol 2003; 111(2 Suppl):520-9.
11. Mucha SM, Baroody FM. Relationships between atopy and bacterial infections. Curr Allergy Asthma Rep2003; 3(3):232-7.
12. Khorasani EN, Fallahi GH, Mansouri F, Rezaei N. The effect of omeprazole on asthmatic adolescents with gastroesophageal reflux disease. Allergy Asthma Proc 2008; 29(5):517-20.
13. Parsons JP, Mastronarde JG. Gastroesophageal reflux disease and asthma. Curr Opin Pulm Med 2010;16(1):60-3.
14. Al-Asoom LI, Al-Rubaish A, Al-Quorain AA, Qutub H, El-Munshid HA. The association of gastroesophageal reflux with bronchial asthma. Can asthma also trigger reflux? Hepatogastroenterology 2006; 53(67):64-72.
15. Richter JE. Medical management of patients with esophageal or supraesophageal gastroesophageal reflux disease. Am J Med 2003; 115 Suppl 3A:179S-87S.
16. Zalzal GH, Tran LP. Pediatric gastroesophageal reflux and laryngopharyngeal reflux. Otolaryngol Clin North Am 2000; 33(1):151-61.
17. Chavoshzadeh Z, Golnabi A, Rezaei N, Mehdizadeh M.Laryngeal foreign body aspiration sdiagnosed as asthma: two case reports and a review of the literature. B-ENT 2011; 7(2):137-40.
18. Gibson RL, Burns JL, Ramsey BW. Pathophysiology and management of pulmonary infections in cystic fibrosis. Am J Respir Crit Care Med 2003; 168(8):918-51.
19. Lyon E, Miller C. Current challenges in cystic fibrosis screening. Arch Pathol Lab Med 2003; 127(9):1133-9.
20. Chinen J, Shearer WT. Secondary immunodeficiencies,including HIV infection. J Allergy Clin Immunol 2010;125(2 Suppl 2):195-203.
21. Kolesnikov AP, Khabarov AS, Kozlov VA. [Diagnosis and differentiated treatment of secondary immunodeficiencies]. Ter Arkh 2001; 73(4):55-9.
22. Gibbons T, Fuchs GJ. Chronic enteropathy: clinical aspects. Nestle Nutr Workshop Ser Pediatr Program2007; 59:89-101.
23. Aghamohammadi A, Pouladi N, Parvaneh N, Yeganeh M, Movahedi M, Gharagolou M, et al. Mortality and morbidity in common variable immunodeficiency. J Trop Pediatr 2007; 53(1):32-8.
24. Boyle JM, Buckley RH. Population prevalence of diagnosed primary immunodeficiency diseases in the United States. J Clin Immunol 2007; 27(5):497-502.
25. Al-Herz W, Bousfiha A, Casanova JL, Chapel H,Conley ME, Cunningham-Rundles C, et al. Primary Immunodeficiency Diseases: an update on the Classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency. Front. Immun 2011; 2.
26. Seymour B, Miles J, Haeney M. Primary antibody deficiency and diagnostic delay. J Clin Pathol 2005; 58(5):546-7.
27. Reda SM, Afifi HM, Amine MM. Primary immunodeficiency diseases in Egyptian children: a single-center study. J Clin Immunol 2009; 29(3):343-51.
28. Al-Herz W. Primary immunodeficiency disorders in Kuwait: first report from Kuwait National Primary Immunodeficiency Registry (2004--2006). J Clin Immunol 2008; 28(2):186-93.
29. Knerr V, Grimbacher B. Primary immunodeficiency registries. Curr Opin Allergy Clin Immunol 2007;7(6):475-80.
30. Kirkpatrick P, Riminton S. Primary immunodeficiency diseases in Australia and New Zealand. J Clin Immunol 2007; 27(5):517-24.
31. Leiva LE, Zelazco M, Oleastro M, Carneiro-Sampaio M, Condino-Neto A, Costa-Carvalho BT, et al. Primary immunodeficiency diseases in Latin America: the second report of the LAGID registry. J Clin Immunol 2007; 27(1):101-8.
32. Aghamohammadi A, Moein M, Farhoudi A, Pourpak Z, Rezaei N, Abolmaali K, et al. Primary immunodeficiency in Iran: first report of the National Registry of PID in Children and Adults. J Clin Immunol 2002; 22(6):375-80.
33. Arnaiz-Villena A, Rodriguez-Gallego C, Timon M, Corell A, Pacheco A, Alvarez-Zapata D, et al. Diseases involving the T-cell receptor/CD3 complex. Crit Rev Oncol Hematol 1995; 19(2):131-47.
34. Bonilla FA, Geha RS. Primary immunodeficiency diseases. J Allergy Clin Immunol 2003; 111(2Suppl):571-81.
35. Buckley RH. Primary cellular immunodeficiencies. J Allergy Clin Immunol 2002; 109(5):747-57.
36. Champi C. Primary immunodeficiency disorders inchildren: prompt diagnosis can lead to lifesaving treatment. J Pediatr Health Care 2002; 16(1):16-21.
37. Fleisher TA. Evaluation of the potentially immunodeficient patient. Adv Intern Med 1996; 41:1-30.
38. Martin P, Lerner A, Johnson L, Lerner DL, Haraguchi S, Good RA, et al. Inherited mannose binding lectin deficiency as evidenced by genetic and immunologic analyses: association with severe recurrent infections. Ann Allergy Asthma Immunol 2003; 91(4):386-92.
39. Moin M, Aghamohammadi A, Farhoudi A, Pourpak Z, Rezaei N, Movahedi M, et al. X-linked agammaglobulinemia: a survey of 33 Iranian patients. Immunol Invest 2004; 33(1):81-93.
40. Stiehm RE. The four most common pediatric immunodeficiencies. Adv Exp Med Biol 2007; 601:15-26.
41. Winkelstein JA, Marino MC, Lederman HM, Jones SM, Sullivan K, Burks AW, et al. X-linked agammaglobulinemia: report on a United States registry of 201 patients. Medicine (Baltimore) 2006; 85(4):193-202.
42. Martire B, Rondelli R, Soresina A, Pignata C, Broccoletti T, Finocchi A, et al. Clinical features, long- term follow-up and outcome of a large cohort of patients with Chronic Granulomatous Disease: an Italian multicenter study. Clin Immunol 2008; 126(2):155-64.
43. Movahedi M, Aghamohammadi A, Rezaei N, Shahnavaz N, Jandaghi AB, Farhoudi A, et al. Chronic granulomatous disease: a clinical survey of 41 patients from the Iranian primary immunodeficiency registry. Int Arch Allergy Immunol 2004; 134(3):253-9.
44. Bacchelli C, Buckridge S, Thrasher AJ, Gaspar HB.Translational mini-review series on immunodeficiency: molecular defects in common variable immuno- deficiency. Clin Exp Immunol 2007; 149(3):401-9.
45. Quinti I, Soresina A, Spadaro G, Martino S, Donnanno S, Agostini C, et al. Long-term follow-up and outcome of a large cohort of patients with common variable immunodeficiency. J Clin Immunol 2007; 27(3):308-16.
46. Rezaei N, Farhoudi A, Pourpak Z, Aghamohammadi A, Moin M, Movahedi M, et al. Neutropenia in Iranian patients with primary immunodeficiency disorders. Haematologica 2005; 90(4):554-6.
47. Rezaei N, Farhoudi A, Ramyar A, Pourpak Z, Aghamohammadi A, Mohammadpour B, et al. Congenital neutropenia and primary immunodeficiency disorders: a survey of 26 Iranian patients. J Pediatr Hematol Oncol 2005; 27(7):351-6.
48. Rezaei N, Moin M, Pourpak Z, Ramyar A, Izadyar M, Chavoshzadeh Z, et al. The clinical, immunohematological, and molecular study of Iranian patients with severe congenital neutropenia. J Clin Immunol 2007; 27(5):525-33.
49. Levy J, Espanol-Boren T, Thomas C, Fischer A, Tovo P, Bordigoni P, et al. Clinical spectrum of X-linked hyper-IgM syndrome. J Pediatr 1997; 131(1 Pt 1):47-54.
50. Ferrari S, Plebani A. Cross-talk between CD40 and CD40L: lessons from primary immune deficiencies. Curr Opin Allergy Clin Immunol 2002; 2(6):489-94.
51. Rezaei N, Aghamohammadi A, Mansouri D, Parvaneh N, Casanova JL. Tuberculosis: a new look at an old disease. Expert Rev Clin Immunol 2011; 7(2):129-31.
52. Segal BH, Leto TL, Gallin JI, Malech HL, Holland SM. Genetic, biochemical, and clinical features of chronic granulomatous disease. Medicine (Baltimore) 2000; 79(3):170-200.
53. Rezaei N, Aghamohammadi A. Hyper-IgE syndrome. J Postgrad Med 2011; 56(2):63-4.
54. Rezaei N, Hedayat M, Aghamohammadi A, Nichols KE. Primary immunodeficiency diseases associated with increased susceptibility to viral infections and malignancies. J Allergy Clin Immunol 2011; 127(6):1329-41 e2; quiz 42-3.
55. Rezaei N, Mahmoudi E, Aghamohammadi A, Das R, Nichols KE. X-linked lymphoproliferative syndrome: a genetic condition typified by the triad of infection, immunodeficiency and lymphoma. Br J Haematol 2011; 152(1):13-30.
56. Wen L, Atkinson JP, Giclas PC. Clinical and laboratory evaluation of complement deficiency. J Allergy Clin Immunol 2004; 113(4):585-93; quiz 94.
57. Altare F, Durandy A, Lammas D, Emile JF, Lamhamedi S, Le Deist F, et al. Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. Science 1998; 280(5368):1432-5.
58. Dupuis S, Doffinger R, Picard C, Fieschi C, Altare F, Jouanguy E, et al. Human interferon-gamma-mediated immunity is a genetically controlled continuous trait that determines the outcome of mycobacterial invasion. Immunol Rev 2000; 178:129-37.
59. Casrouge A, Zhang SY, Eidenschenk C, Jouanguy E, Puel A, Yang K, et al. Herpes simplex virus encephalitis in human UNC-93B deficiency. Science2006; 314(5797):308-12.
60. Perez de Diego R, Sancho-Shimizu V, Lorenzo L, Puel A, Plancoulaine S, Picard C, et al. Human TRAF3 adaptor molecule deficiency leads to impaired Toll-like receptor 3 response and susceptibility to herpes simplex encephalitis. Immunity 2010; 33(3):400-11.
61. Zhang SY, Jouanguy E, Ugolini S, Smahi A, Elain G, Romero P, et al. TLR3 deficiency in patients with herpes simplex encephalitis. Science 2007;317(5844):1522-7.
62. Sancho-Shimizu V, Perez de Diego R, Lorenzo L, Halwani R, Alangari A, Israelsson E, et al. Herpes simplex encephalitis in children with autosomal recessive and dominant TRIF deficiency. J Clin Invest 2011; 121(12):4889-902.
63. Rezaei N, Pourpak Z, Aghamohammadi A, Farhoudi A, Movahedi M, Gharagozlou M, et al. Consanguinity in primary immunodeficiency disorders; the report from Iranian Primary Immunodeficiency Registry. Am J Reprod Immunol 2006; 56(2):145-51.
64. Aghamohammadi A, Moin M, Rezaei N. History of primary immunodeficiency diseases in Iran. Iran J Pediatr 2010; 20(1):16-34.
65. Rezaei N, Mohammadinejad P, Aghamohammadi A.The demographics of primary immunodeficiency diseases across the unique ethnic groups in Iran, and approaches to diagnosis and treatment. Ann N Y Acad Sci 2011; 1238(1):24-32.
66. Rezaei N, Aghamohammadi A, Moin M, Pourpak Z, Movahedi M, Gharagozlou M, et al. Frequency and clinical manifestations of patients with primary immunodeficiency disorders in Iran: update from the Iranian Primary Immunodeficiency Registry. J Clin Immunol 2006; 26(6):519-32.
67. Introne W, Boissy RE, Gahl WA. Clinical, molecular, and cell biological aspects of Chediak-Higashi syndrome. Mol Genet Metab 1999; 68(2):283-303.
68. Wisniewski SA, Kobielak A, Trzeciak WH, Kobielak K. Recent advances in understanding of the molecular basis of anhidrotic ectodermal dysplasia: discovery of a ligand, ectodysplasin A and its two receptors. J Appl Genet 2002; 43(1):97-107.
69. O'Driscoll M, Cerosaletti KM, Girard PM, Dai Y, Stumm M, Kysela B, et al. DNA ligase IV mutations identified in patients exhibiting developmental delay and immunodeficiency. Mol Cell 2001; 8(6):1175-85.
70. van der Burgt I, Chrzanowska KH, Smeets D, Weemaes C. Nijmegen breakage syndrome. J Med Genet 1996;33(2):153-6.
71. Webster AD, Barnes DE, Arlett CF, Lehmann AR, Lindahl T. Growth retardation and immunodeficiency in a patient with mutations in the DNA ligase I gene. Lancet 1992; 339(8808):1508-9.
72. Franceschini P, Martino S, Ciocchini M, Ciuti E, Vardeu MP, Guala A, et al. Variability of clinical and immunological phenotype in immunodeficiency- centromeric instability-facial anomalies syndrome. Report of two new patients and review of the literature. Eur J Pediatr 1995; 154(10):840-6.
73. Grimbacher B, Holland SM, Gallin JI, Greenberg F, Hill SC, Malech HL, et al. Hyper-IgE syndrome with recurrent infections--an autosomal dominant multisystem disorder. N Engl J Med 1999; 340(9):692-702.
74. Aghamohammadi A, Fiorini M, Moin M, Parvaneh N, Teimourian S, Yeganeh M, et al. Clinical, immunological and molecular characteristics of 37 Iranian patients with X-linked agammaglobulinemia. Int Arch Allergy Immunol 2006; 141(4):408-14.
75. Etzioni A, Sturla L, Antonellis A, Green ED, Gershoni- Baruch R, Berninsone PM, et al. Leukocyte adhesion deficiency (LAD) type II/carbohydrate deficient glycoprotein (CDG) IIc founder effect and genotype/phenotype correlation. Am J Med Genet2002; 110(2):131-5.
76. Rosenzweig SD, Holland SM. Phagocyte immunodeficiencies and their infections. J Allergy Clin Immunol 2004; 113(4):620-6.
77. Parvaneh N, Mamishi S, Rezaei A, Rezaei N, Tamizifar B, Parvaneh L, et al. Characterization of 11 new cases of leukocyte adhesion deficiency type 1 with seven novel mutations in the ITGB2 gene. J Clin Immunol 2010; 30(5):756-60.
78. Bunting M, Harris ES, McIntyre TM, Prescott SM, Zimmerman GA. Leukocyte adhesion deficiency syndromes: adhesion and tethering defects involving beta 2 integrins and selectin ligands. Curr Opin Hematol 2002; 9(1):30-5.
79. Etzioni A, Tonetti M. Leukocyte adhesion deficiency II-from A to almost Z. Immunol Rev 2000;178:138-47.
80. Badolato R, Fontana S, Notarangelo LD, Savoldi G.Congenital neutropenia: advances in diagnosis and treatment. Curr Opin Allergy Clin Immunol 2004;4(6):513-21.
81. Lin MT, Chien YH, Shyur SD, Huang LH, Chiang YC, Wen DC, et al. De novo mutation in the BTK gene of atypical X-linked agammaglobulinemia in a patient with recurrent pyoderma. Ann Allergy Asthma Immunol 2006; 96(5):744-8.
82. Yeganeh M, Heidarzade M, Pourpak Z, Parvaneh N, Rezaei N, Gharagozlou M, et al. Severe combined immunodeficiency: a cohort of 40 patients. Pediatr Allergy Immunol 2008; 19(4):303-6.
83. Kirkpatrick CH. Chronic mucocutaneous candidiasis.Pediatr Infect Dis J 2001; 20(2):197-206.
84. Glocker EO, Hennigs A, Nabavi M, Schaffer AA, Woellner C, Salzer U, et al. A homozygous CARD9 mutation in a family with susceptibility to fungal infections. N Engl J Med 2009; 361(18):1727-35.
85. Ahonen P, Myllarniemi S, Sipila I, Perheentupa J.Clinical variation of autoimmune polyendocrinopathy- candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients. N Engl J Med 1990;322(26):1829-36.
86. Lilic D. New perspectives on the immunology of chronic mucocutaneous candidiasis. Curr Opin Infect Dis 2002; 15(2):143-7.
87. Torgerson TR, Ochs HD. Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome: a model of immune dysregulation. Curr Opin Allergy Clin Immunol 2002; 2(6):481-7.
88. Reed WB, Epstein WL, Boder E, Sedgwick R.Cutaneous manifestations of ataxia-telangiectasia. Jama 1966; 195(9):746-53.
89. Rezaei N, Moazzami K, Aghamohammadi A, Klein C.Neutropenia and primary immunodeficiency diseases. Int Rev Immunol 2009; 28(5):335-66.
90. Aghamohammadi A, Moazzami K, Rezaei N, Karimi A, Movahedi M, Gharagozlou M, et al. ENT manifestations in Iranian patients with primary antibody deficiencies. J Laryngol Otol 2008; 122(4):409-13.
91. Aghamohammadi A, Moin M, Karimi A, Naraghi M, Zandieh F, Isaeian A, et al. Immunologic evaluation of patients with recurrent ear, nose, and throat infections. Am J Otolaryngol 2008; 29(6):385-92.
92. Aghamohammadi A, Farhoudi A, Moin M, Rezaei N,Kouhi A, Pourpak Z, et al. Clinical and immunological features of 65 Iranian patients with common variable immunodeficiency. Clin Diagn Lab Immunol 2005;12(7):825-32.
93. Aghamohammadi A, Parvaneh N, Rezaei N, Moazzami K, Kashef S, Abolhassani H, et al. Clinical and Laboratory Findings in Hyper-IgM Syndrome with Novel CD40L and AICDA Mutations. J Clin Immunol 2009.
94. Plebani A, Soresina A, Rondelli R, Amato GM, Azzari C, Cardinale F, et al. Clinical, immunological, and molecular analysis in a large cohort of patients with X- linked agammaglobulinemia: an Italian multicenter study. Clin Immunol 2002; 104(3):221-30.
95. May A, Zielen S, von Ilberg C, Weber A.Immunoglobulin deficiency and determination of pneumococcal antibody titers in patients with therapy- refractory recurrent rhinosinusitis. Eur Arch Otorhinolaryngol 1999; 256(9):445-9.
96. Aghamohammadi A, Parvaneh N, Tirgari F, Mahjoob F, Movahedi M, Gharagozlou M, et al. Lymphoma of mucosa-associated lymphoid tissue in common variable immunodeficiency. Leuk Lymphoma 2006; 47(2):343-6.
97. Bates CA, Ellison MC, Lynch DA, Cool CD, Brown KK, Routes JM. Granulomatous-lymphocytic lung disease shortens survival in common variable immunodeficiency. J Allergy Clin Immunol 2004;114(2):415-21.
98. Berrington JE, Flood TJ, Abinun M, Galloway A, Cant AJ. Unsuspected Pneumocystis carinii pneumonia at presentation of severe primary immunodeficiency. Arch Dis Child 2000; 82(2):144-7.
99. Cetin E, Lee EY. Pneumocystis carinii pneumonia in an infant with hypogammaglobulinemia. Pediatr Radiol 2007; 37(3):329.
100. Freeman AF, Davis J, Anderson VL, Barson W, Darnell DN, Puck JM, et al. Pneumocystis jiroveci infection in patients with hyper-immunoglobulin E syndrome. Pediatrics 2006; 118(4):1271-5.
101. Freeman AF, Kleiner DE, Nadiminti H, Davis J, Quezado M, Anderson V, et al. Causes of death in hyper-IgE syndrome. J Allergy Clin Immunol 2007;119(5):1234-40.
102. Siddiqui S, Anderson VL, Hilligoss DM, Abinun M, Kuijpers TW, Masur H, et al. Fulminant mulch pneumonitis: an emergency presentation of chronic granulomatous disease. Clin Infect Dis 2007;45(6):673-81.
103. Sweinberg SK, Wodell RA, Grodofsky MP, Greene JM, Conley ME. Retrospective analysis of the incidence of pulmonary disease in hypogammaglobulinemia. J Allergy Clin Immunol 1991; 88(1):96-104.
104. Tabatabaie P, Aghamohammadi A, Mamishi S, Isaeian A, Heidari G, Abdollahzade S, et al. Evaluation of humoral immune function in patients with bronchiectasis. Iran J Allergy Asthma Immunol 2008;7(2):69-77.
105. Thickett KM, Kumararatne DS, Banerjee AK, Dudley R, Stableforth DE. Common variable immune deficiency: respiratory manifestations, pulmonary function and high-resolution CT scan findings. Qjm 2002; 95(10):655-62.
106. Pasic S, Jankovic I, Rosic R, Ognjanovic M.Pneumocystis carinii pneumonitis in haemophagocytic lymphohistiocytosis. Acta Paediatr 2001; 90(12):1480-2.
107. Winkelstein JA, Marino MC, Ochs H, Fuleihan R, Scholl PR, Geha R, et al. The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients. Medicine (Baltimore) 2003; 82(6):373-84.
108. Marcy TW, Reynolds HY. Pulmonary consequences of congenital and acquired primary immunodeficiency states. Clin Chest Med 1989; 10(4):503-19.
109. Blore J, Haeney MR. Primary antibody deficiency and diagnostic delay. Bmj 1989; 298(6672):516-7.
110. Johnston SL, Hill SJ, Lock RJ, Dwight JF, Unsworth DJ, Gompels MM. Echocardiographic abnormalities in primary antibody deficiency. Postgrad Med J 2004;80(942):214-8.
111. Khodadad A, Aghamohammadi A, Parvaneh N, Rezaei N, Mahjoob F, Bashashati M, et al. Gastrointestinal manifestations in patients with common variable immunodeficiency. Dig Dis Sci 2007; 52(11):2977-83.
112. Rodrigues F, Davies EG, Harrison P, McLauchlin J, Karani J, Portmann B, et al. Liver disease in children with primary immunodeficiencies. J Pediatr 2004;145(3):333-9.
113. Waldmann TA, Misiti J, Nelson DL, Kraemer KH.Ataxia-telangiectasis: a multisystem hereditary disease with immunodeficiency, impaired organ maturation, x-ray hypersensitivity, and a high incidence of neoplasia. Ann Intern Med 1983; 99(3):367-79.
114. Nowak-Wegrzyn A, Crawford TO, Winkelstein JA,Carson KA, Lederman HM. Immunodeficiency and infections in ataxia-telangiectasia. J Pediatr 2004;144(4):505-11.
115. Diaconu G, Grigore I, Moisa SM, Burlea M. [Ataxia- telangiectasia syndrome. Clinical and diagnostic aspects]. Rev Med Chir Soc Med Nat Iasi 2007;111(2):386-90.
116. Menasche G, Ho CH, Sanal O, Feldmann J, Tezcan I, Ersoy F, et al. Griscelli syndrome restricted to hypopigmentation results from a melanophilin defect (GS3) or a MYO5A F-exon deletion (GS1). J Clin Invest 2003; 112(3):450-6.
117. Wright PF, Hatch MH, Kasselberg AG, Lowry SP, Wadlington WB, Karzon DT. Vaccine- associated poliomyelitis in a child with sex- linked agammaglobulinemia. J Pediatr 1977; 91(3):408-12.
118. Shahmahmoodi S, Mamishi S, Aghamohammadi A, Aghazadeh N, Tabatabaie H, Gooya MM, et al. Vaccine-associated paralytic poliomyelitis in immunodeficient children, Iran, 1995-2008. Emerg Infect Dis 2010; 16(7):1133-6.
119. Carnide EM, Jacob CM, Pastorino AC, Bellinati-Pires R, Costa MB, Grumach AS. Chediak-Higashi syndrome: presentation of seven cases. Sao Paulo Med J 1998; 116(6):1873-8.
120. Quartier P, Foray S, Casanova JL, Hau- Rainsard I, Blanche S, Fischer A. Enteroviral meningoencephalitis in X-linked agammaglobulinemia: intensive immunoglobulin therapy and sequential viral detection in cerebrospinal fluid by polymerase chain reaction. Pediatr Infect Dis J 2000; 19(11):1106-8.
121. Sakiniene E, Bremell T, Tarkowski A. Complement depletion aggravates Staphylococcus aureus septicaemia and septic arthritis. Clin Exp Immunol 1999; 115(1):95-102.
122. Franz A, Webster AD, Furr PM, Taylor-Robinson D.Mycoplasmal arthritis in patients with primary immunoglobulin deficiency: clinical features and outcome in 18 patients. Br J Rheumatol 1997; 36(6):661-8.
123. Rezaei N, Abolhassani H, Aghamohammadi A, Ochs HD. Indications and safety of intravenous and subcutaneous immunoglobulin therapy. Expert Rev Clin Immunol 2011; 7(3):301-16.
124. Woellner C, Gertz EM, Schaffer AA, Lagos M, Perro M, Glocker EO, et al. Mutations in STAT3 and diagnostic guidelines for hyper-IgE syndrome. J Allergy Clin Immunol 2010; 125(2):424-32.
125. Yin EZ, Frush DP, Donnelly LF, Buckley RH. Primary immunodeficiency disorders in pediatric patients: clinical features and imaging findings. AJR Am J Roentgenol 2001; 176(6):1541-52.
126. Lederman HM, Winkelstein JA. X-linked agammaglobulinemia: an analysis of 96 patients. Medicine (Baltimore) 1985; 64(3):145-56.
127. Facchetti F, Blanzuoli L, Ungari M, Alebardi O, Vermi W. Lymph node pathology in primary combined immunodeficiency diseases. Springer Semin Immunopathol 1998; 19(4):459-78.
128. Aguilera NS, Auerbach A, Barekman CL, Lichy J, Abbondanzo SL. Activation-induced cytidine deaminase expression in diffuse large B-cell lymphoma with a paracortical growth pattern: a lymphoma of possible interfollicular large B-cell origin. Arch Pathol Lab Med 2010; 134(3):449-56.
129. Revy P, Muto T, Levy Y, Geissmann F, Plebani A, Sanal O, et al. Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2). Cell 2000;102(5):565-75.
130. Hermans PE, Diaz-Buxo JA, Stobo JD. Idiopathic late- onset immunoglobulin deficiency. Clinical observations in 50 patients. Am J Med 1976; 61(2):221-37.
131. Wood P, Stanworth S, Burton J, Jones A, Peckham DG, Green T, et al. Recognition, clinical diagnosis and management of patients with primary antibody deficiencies: a systematic review. Clin Exp Immunol 2007; 149(3):410-23.
132. Moin M, Aghamohammadi A, Kouhi A, Tavassoli S, Rezaei N, Ghaffari SR, et al. Ataxia-telangiectasia in Iran: clinical and laboratory features of 104 patients. Pediatr Neurol 2007; 37(1):21-8.
133. Poppema S, Maggio E, van den Berg A. Development of lymphoma in Autoimmune Lymphoproliferative Syndrome (ALPS) and its relationship to Fas gene mutations. Leuk Lymphoma 2004; 45(3):423-31.
134. Gompels MM, Hodges E, Lock RJ, Angus B, White H, Larkin A, et al. Lymphoproliferative disease in antibody deficiency: a multi-centre study. Clin Exp Immunol 2003; 134(2):314-20.
135. Minegishi Y, Lavoie A, Cunningham-Rundles C,Bedard PM, Hebert J, Cote L, et al. Mutations in activation-induced cytidine deaminase in patients with hyper IgM syndrome. Clin Immunol 2000; 97(3):203-10.
136. Hague RA, Rassam S, Morgan G, Cant AJ.Early diagnosis of severe combined immunodeficiency syndrome. Arch Dis Child 1994;70(4):260-3.
137. Filipovich AH. Hemophagocytic lymphohistiocytosis and related disorders. Curr Opin Allergy Clin Immunol 2006; 6(6):410-5.
138. Pasic S, Micic D, Kuzmanovic M. Epstein-Barr virus- associated haemophagocytic lymphohistiocytosis in Wiskott-Aldrich syndrome. Acta Paediatr 2003;92(7):859-61.
139. Cham B, Bonilla MA, Winkelstein J. Neutropenia associated with primary immunodeficiency syndromes. Semin Hematol 2002; 39(2):107-12.
140. Bohn G, Welte K, Klein C. Severe congenital neutropenia: new genes explain an old disease. Curr Opin Rheumatol 2007; 19(6):644-50.
141. Rezaei N, Aghamohammadi A, Ramyar A, Pan-Hammarstrom Q, Hammarstrom L. Severe congenital neutropenia or hyper-IgM syndrome? A novel mutation of CD40 ligand in a patient with severe neutropenia. Int Arch Allergy Immunol 2008;147(3):255-9.
142. Ramyar A, Aghamohammadi A, Moazzami K, Rezaei N, Yeganeh M, Cheraghi T, et al. Presence of Idiopathic Thrombocytopenic Purpura and autoimmune hemolytic anemia in the patients with common variable immunodeficiency. Iran J Allergy Asthma Immunol 2008; 7(3):169-75.
143. Hannibal MC, Torgerson T. IPEX Syndrome. Editors In: Pagon RA, Bird TD, Dolan CR, Stephens K, Adam MP, editors. GeneReviews™ [Internet]. Seattle (WA): University of Washington, Seattle; 1993.
144. Hernandez-Nieto L, Yamazaki-Nakashimada MA, Lieberman-Hernandez E, Espinosa-Padilla SE. Autoimmune thrombocytopenic purpura in partial DiGeorge syndrome: case presentation. J Pediatr Hematol Oncol 2011; 33(6):465-6.
145. Puck JM. Population-based newborn screening for severe combined immunodeficiency: steps toward implementation. J Allergy Clin Immunol 2007; 120(4):760-8.
146. Puck JM. Population-based newborn screening for severe combined immunodeficiency. Biol Blood Marrow Transplant 2008; 14(1 Suppl 1):78-80.
147. Sewell WA, Khan S, Dore PC. Early indicators of immunodeficiency in adults and children: protocols for screening for primary immunological defects. Clin Exp Immunol 2006; 145(2):201-3.
148. de Vries E. Patient-centred screening for primary immunodeficiency: a multi-stage diagnostic protocol designed for non-immunologists. Clin Exp Immunol 2006; 145(2):204-14.
149. Rezaei N, Aghamohammadi A, Siadat SD, Nejati M, Ahmadi H, Moin M, et al. Serum bactericidal antibody response to serogroup C polysaccharide meningococcal vaccination in children with primary antibody deficiencies. Vaccine 2007; 25(29):5308-14.
150. Puck JM. Neonatal screening for severe combined immune deficiency. Curr Opin Allergy Clin Immunol 2007; 7(6):522-7.
151. Skoda-Smith S, Barrett D. When earaches and sore throats become more than a pain in the neck. Contemp Pediatr 2000; 17:156.
152. Mahmoodi M, Aghamohammadi A, Rezaei N, Lessan- Pezeshki M, Pourmand G, Mohagheghi MA, et al. Antibody response to pneumococcal capsular polysaccharide vaccination in patients with chronic kidney disease. Eur Cytokine Netw 2009; 20(2):69-74.
153. Bush A. Recurrent respiratory infections. Pediatr Clin North Am 2009; 56(1):67-100.
154. Bonilla FA, Bernstein IL, Khan DA, Ballas ZK, Chinen J, Frank MM, et al. Practice parameter for the diagnosis and management of primary immunodeficiency. Ann Allergy Asthma Immunol 2005; 94(5 Suppl 1):S1-63.
155. Buckley RH. The multiple causes of human SCID. J Clin Invest 2004; 114(10):1409-11.
156. Fischer A. Primary T-lymphocyte immunodeficiencies.Clin Rev Allergy Immunol 2001; 20(1):3-26.
157. McKinney RE , Katz SL, Wilfert CM. Chronic enteroviral meningoencephalitis in gammaglobulinemic patients. Rev Infect Dis 1987;9(2):334-56.
158. Hsu CT, Lin YT, Yang YH, Chiang BL. The hyperimmunoglobulin E syndrome. J Microbiol Immunol Infect 2004; 37(2):121-3.
159. Slatter MA, Gennery AR. Clinical immunology review series: an approach to the patient with recurrent infections in childhood. Clin Exp Immunol 2008;152(3):389-96.
160. Rezaei N, Aghamohammadi A, Notarangelo LD.Primary immunodeficiency diseases: definition, diagnosis and management. Berlin Heidelberg: Springer-Verlag; 2008.
| Files | ||
| Issue | Vol 11, No 2 (2012) | |
| Section | Articles | |
| Keywords | ||
| Approach Diagnosis Primary immunodeficiency diseases Recurrent infections | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
